Maria Chapela

Maria Chapela

Senior Principal Scientist

GSK

Maria Chapela holds a degree in Chemistry from the University of Santiago de Compostela and a PhD in Organic Chemistry from the University of Vigo, Spain. She has over 20 years of experience in the pharmaceutical industry. At GSK, she has held various roles in Analytical Development within the CMC area, focusing on forced degradation studies and the development and validation of trace analytical methods for mutagenic impurities and nitrosamine drug substance-related impurities (NDSRIs). Maria contributes to mutagenic impurity control strategies for pharmaceutical products, supporting projects from early phase to market application, including contributions to regulatory submissions.